Valuing Mortality Risk Reductions

James Hammitt and Lisa Robinson smiling at camera.

CHDS faculty Lisa A. Robinson and James K. Hammitt, and research staff Lucy O’Keeffe, recently published “Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis.”

This article is the culmination of a major effort to integrate work on valuing mortality risk reductions (commonly referred to as the value per statistical life, VSL) in low- and middle-income countries, as part of the Guidelines for Benefit-Cost Analysis project. The article is currently available on FirstView, and will be published as part of a Journal of Benefit-Cost Analysis in the forthcoming special issue on “Benefit-Cost Analysis in Low- and Middle-Income Countries: Methods and Case Studies”.

Learn more: Read about benefit-cost analysis.

Related news: Teaching Benefit-Cost Analysis
Related news: Ethics in Health Care